Literature DB >> 17460406

Efficacy of 25% diluted fluticasone propionate 0.05% cream as wet-wrap treatment in cutaneous mastocytosis.

Rogier Heide1, Flora B de Waard-van der Spek, Jan C den Hollander, Bhupendra Tank, Arnold P Oranje.   

Abstract

BACKGROUND: Mastocytosis is a disorder that can be subdivided into two forms: cutaneous and systemic. Patients with cutaneous mastocytosis only may suffer from cosmetic problems. Topical steroid application has been shown to be effective in cases of limited skin lesions.
METHODS: A case-controlled pilot study was conducted during a 6-weeks treatment using diluted 25% fluticasone propionate 0.05% cream under wet-wrap occlusion in 5 adults and 6 children. Improvement was measured up to the 24th week after treatment using the SCORMA Index.
RESULTS: The results of this pilot study showed a partial but clear cosmetic improvement in 9 of the 11 patients. The mean SCORMA Index decreased after treatment from 38 to 26.
CONCLUSION: 25% dilution of fluticasone propionate 0.05% cream under wet-wrap occlusion is an alternative treatment modality for alleviating the symptoms of cutaneous mastocytosis, but the improvement may be moderate and fall short of the patient's expectations. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460406     DOI: 10.1159/000100885

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  4 in total

Review 1.  Current approach to cutaneous mastocytosis in childhood.

Authors:  Zeynep Tamay; Deniz Özçeker
Journal:  Turk Pediatri Ars       Date:  2016-09-01

2.  The efficacy of clobetasol propionate with varying dilutions of emollient determined by histamine wheal suppression test.

Authors:  M Barathi; Reena Rai; C R Srinivas
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

Review 3.  Update on diagnosis and treatment of mastocytosis.

Authors:  Knut Brockow; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2011-08       Impact factor: 4.806

4.  The care pathway for children with urticaria, angioedema, mastocytosis.

Authors:  Giuliana Ferrante; Valeria Scavone; Maria Concetta Muscia; Emilia Adrignola; Giovanni Corsello; Giovanni Passalacqua; Stefania La Grutta
Journal:  World Allergy Organ J       Date:  2015-02-02       Impact factor: 4.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.